| Current Price | $86.98 | Mkt Cap | $128.6B |
|---|---|---|---|
| Open | $87.25 | P/E Ratio | 39.94 |
| Prev. Close | $86.72 | Div. (Yield) | $4.28 (4.9%) |
| Daily Range | $86.80 - $87.70 | Volume | 1,491,817 |
| 52-Wk Range | $62.68 - $92.30 | Avg. Daily Vol. | 7,580,582 |
| Current Price | $86.98 | Mkt Cap | $128.6B |
|---|---|---|---|
| Open | $87.25 | P/E Ratio | 39.94 |
| Prev. Close | $86.72 | Div. (Yield) | $4.28 (4.9%) |
| Daily Range | $86.80 - $87.70 | Volume | 1,491,817 |
| 52-Wk Range | $62.68 - $92.30 | Avg. Daily Vol. | 7,580,582 |
The best Bull and Bear pitches based on recency and number of recommendations.
Sold off due to patent cliff concerns and Hep C drug discounts. I believe this is an overreaction and the stock will recover. There is more in the pipeline than the P/E - 13 - would imply.
This mega-cap has made a big run since Express Scripts's announcement that it will take AbbVie's hep C treatment in lieu of Gilead's. Also, an amazing preponderance of CAPS bulls favor this stock beating the market from here -- very interesting. For… More
Read the most recent pitches from players about ABBV.
Recs
Groovy99
(< 20)
Submitted: 10/4/2019 2:27:05 AM :
Start Price:
$72.54
NYSE:ABBV Score:
+11.56
Blue chip dividend growth stock
Recs
TMFBigFrog
(94.58)
Submitted: 7/10/2019 11:32:31 PM :
Start Price:
$69.50
NYSE:ABBV Score:
+19.62
The Allergan merger buys it time
Recs
Kakabeka
(63.59)
Submitted: 6/29/2019 10:12:16 PM :
Start Price:
$70.34
NYSE:ABBV Score:
+17.58
Oversold re Allergan purchase
Find the members with the highest scoring picks in ABBV.
jonboy13 (98.56) Score: +144.54
The Score Leader is the player with the highest score across all their picks in ABBV.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| concealedweaponR | 33.50 | 1/10/2013 |
|
5Y | $25.71 | +238.27% | +114.58% | +123.69 | 0 Comment | |
| deliman723 | 65.17 | 1/10/2013 |
|
5Y | $25.71 | +238.27% | +114.58% | +123.69 | 0 Comment | |
| cooleyly | 57.31 | 1/10/2013 |
|
5Y | $25.71 | +238.27% | +114.58% | +123.69 | 0 Comment | |
|
mattmmurphy | 68.33 | 1/10/2013 |
|
5Y | $25.71 | +238.27% | +114.58% | +123.69 | 0 Comment |
| GW1000 | 91.71 |
|
|
5Y | $25.71 | +238.27% | +114.58% | +123.69 | 0 Comment | |
|
|
valari25 | 99.85 |
|
|
5Y | $25.71 | +238.27% | +114.58% | +123.69 | 0 Comment |
| pirotta | < 20 | 1/10/2013 |
|
5Y | $25.71 | +238.27% | +114.58% | +123.69 | 0 Comment | |
| armydave | 55.35 |
|
|
5Y | $25.71 | +238.27% | +114.58% | +123.69 | 0 Comment | |
| drjohn432 | < 20 | 1/10/2013 |
|
5Y | $25.71 | +238.27% | +114.58% | +123.69 | 0 Comment | |
|
|
kinosternon | 99.18 | 1/9/2013 |
|
5Y | $25.83 | +236.74% | +115.57% | +121.17 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
